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Six-month Expulsion of Postplacental Copper Intrauterine Devices Placed
After Vaginal Delivery
Abstract
Background
Immediate placement of an intrauterine device after vaginal delivery is safe and convenient, but longitudinal
data describing clinical outcomes have been limited.
Objective
We sought to determine the proportion of TCu380A (copper) intrauterine devices expelled, partially
expelled, malpositioned, and retained, as well as contraceptive use by 6 months postpartum, and determine
risk factors for expulsion and partial expulsion.
Study Design
In this prospective, observational study, women who received a postplacental TCu380A intrauterine device at
vaginal delivery were enrolled postpartum. Participants returned for clinical follow-up at 6 weeks, and for a
research visit with a pelvic exam and ultrasound at 6 months. We recorded intrauterine device outcomes and
6-month contraceptive use. Partial expulsion was defined as an intrauterine device protruding from the
external cervical os, or a transvaginal ultrasound showing the distal end of the intrauterine device below the
internal os of the cervix. Multinomial logistic regression models identified risk factors associated with
expulsion and partial expulsion by 6 months. The area under the receiver operating characteristics curve was
used to assess the ability of a string check to predict the correct placement of a postplacental intrauterine
device. The primary outcome was the proportion of intrauterine devices expelled at 6 months.
Results
We enrolled 200 women. Of 162 participants with follow-up data at 6 months, 13 (8.0%; 95% confidence
interval, 4.7–13.4%) experienced complete expulsion and 26 (16.0%; 95% confidence interval, 11.1–22.6%)
partial expulsion. Of 25 malpositioned intrauterine devices (15.4%; 95% confidence interval, 10.2–21.9%), 14
were not at the fundus (8.6%; 95% confidence interval, 5.2–14.1%) and 11 were rotated within the uterus
(6.8%; 95% confidence interval, 3.8–11.9%). Multinomial logistic regression modeling indicated that higher
parity (odds ratio, 2.05; 95% confidence interval, 1.21–3.50; P = .008) was associated with expulsion.
Provider specialty (obstetrics vs family medicine; odds ratio, 5.31; 95% confidence interval, 1.20–23.59; P =
.03) and gestational weight gain (normal vs excess; odds ratio, 9.12; 95% confidence interval, 1.90–43.82; P =
.004) were associated with partial expulsion. Long-acting reversible contraceptive method use at 6 months
was 80.9% (95% confidence interval, 74.0–86.6%). At 6 weeks postpartum, 35 of 149 (23.5%; 95%
confidence interval, 16.9–31.1%) participants had no intrauterine device strings visible. Sensitivity of a string
check to detect an incorrectly positioned intrauterine device was 36.2%, and specificity of the string check to
predict a correctly positioned intrauterine device was 84.5%. This corresponds to an area under the receiver
operating characteristics curve of 0.5.
Conclusion
This prospective assessment of postplacental TCu380A intrauterine device placement, with ultrasound to
This journal article is available at ScholarlyCommons: https://repository.upenn.edu/obgyn_papers/2
confirm device position, finds a complete intrauterine device expulsion proportion of 8.0% at 6 months. The
association of increasing parity with expulsion is consistent with prior research. The clinical significance of
covariates associated with partial expulsion (provider specialty and gestational weight gain) is unclear. Due to
the observational study design, any associations cannot imply causality. The proportion of partially expelled
and malpositioned intrauterine devices was high, and the area under the receiver operating characteristics
curve of 0.5 indicates that a string check is a poor test for assessing device position. Women considering a
postplacental intrauterine device should be counseled about the risk of position abnormalities, as well as the
possibility of nonvisible strings, which may complicate clinical follow-up. The clinical significance of
intrauterine device position abnormalities is unknown; future research should evaluate the influence of
malposition and partial expulsion on contraceptive effectiveness and side effects.
Keywords
copper intrauterine device, intrauterine device, intrauterine device complication, intrauterine device
expulsion, intrauterine device retention, long-acting reversible contraception, postpartum contraception,
postpartum intrauterine device, postplacental intrauterine device, TCu380A intrauterine device, vaginal
delivery
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Abstract
Background: Immediate placement of an intrauterine device (IUD) after vaginal delivery is safe 
and convenient, but longitudinal data describing clinical outcomes have been limited.
Objectives: To determine the proportion of TCu380A (copper) IUDs devices expelled, partially 
expelled, malpositioned, and retained, as well as contraceptive use by 6 months postpartum. To 
determine risk factors for expulsion and partial expulsion.
Study Design: In this prospective, observational study, women who received a postplacental 
TCu380A IUD at vaginal delivery were enrolled postpartum. Participants returned for clinical 
follow-up at 6 weeks, and for a research visit with a pelvic exam and ultrasound at 6 months. We 
recorded IUD outcomes and 6-month contraceptive use. Partial expulsion was defined as an IUD 
protruding from the external cervical os, or a transvaginal ultrasound showing the distal end of the 
IUD below the internal os of the cervix. Multinomial logistic regression models identified risk 
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factors associated with expulsion and partial expulsion by 6 months. The area under the receiver-
operating characteristics (ROC) curve was used to assess the ability of a string check to predict the 
correct placement of a postplacental IUD. The primary outcome was the proportion of IUDs 
expelled at 6 months.
Results: We enrolled 200 women. Of 162 participants with follow-up data at 6 months, 13 
(8.0%, 95% CI 4.7%–13.4%), experienced complete expulsion and 26 (16.0%, 95% CI 11.1%–
22.6%) partial expulsion (see Figure 1). Of 25 malpositioned IUDs (15.4%, 95% CI 10.2%–
21.9%), 14 were not at the fundus (8.6%, 95% CI 5.2%–14.1%) and 11 were rotated within the 
uterus (6.8%, 95% CI 3.8%–11.9%). Multinomial logistic regression modeling indicated that 
higher parity (OR 2.05; 95% CI 1.21–3.50, p=0.008) was associated with expulsion. Provider 
specialty (Obstetrics vs. Family Medicine; OR 5.31, 95% CI 1.20–23.59; p=0.03) and gestational 
weight gain (normal vs. excess; OR 9.12, 95% CI 1.90–43.82; p=0.004) were associated with 
partial expulsion. Long-acting reversible contraceptive method use at 6 months was 80.9% (95% 
CI 74.0%–86.6%).
At 6 weeks postpartum, 35 of 149 (23.5%, 95% CI 16.9%–31.1%) participants had no IUD strings 
visible. Sensitivity of a string check to detect an incorrectly positioned intrauterine device was 
36.2%, and specificity of the string check to predict a correctly positioned intrauterine device was 
84.5%. This corresponds to an area under the ROC curve of 0.5.
Conclusion: This prospective assessment of postplacental TCu380A intrauterine device 
placement, with ultrasound to confirm device position, finds a complete intrauterine device 
expulsion proportion of 8.0% at 6 months. The association of increasing parity with expulsion is 
consistent with prior research. The clinical significance of covariates associated with partial 
expulsion (provider specialty and gestational weight gain) is unclear. Due to the observational 
study design, any associations cannot imply causality.
The proportion of partially expelled and malpositioned IUDs was high, and the area under the 
ROC curve of 0.5 indicates that a string check is a poor test for assessing device position. Women 
considering a postplacental IUD should be counseled about the risk of position abnormalities, as 
well as the possibility of non-visible strings, which may complicate clinical follow-up. The 
clinical significance of IUD position abnormalities is unknown; future research should evaluate the 
influence of malposition and partial expulsion on contraceptive effectiveness and side effects.
Keywords
TCu380A IUD; copper IUD; intrauterine device; IUD complication; IUD expulsion; IUD 
retention; LARC; long-acting reversible contraception; postpartum contraception; postplacental 
IUD; postpartum IUD; vaginal delivery
Introduction
Facilitation of reproductive life planning and commensurate contraception counseling and 
provision are key elements of postpartum care.1 The use of a postplacental intrauterine 
device (IUD) for postpartum contraception offers several advantages: the IUD is a highly 
effective method,2,3 women are often highly motivated to begin contraception after giving 
birth, and most have ready access to health care during delivery.4 Offering long-acting 
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reversible contraception (LARC) at delivery has become increasingly popular in the United 
States, and 35 states have proposed or accepted guidelines to enable Medicaid coverage of 
LARC placement during the hospitalization for delivery.5
Although postplacental IUD placement has a long safety record,6 literature describing 
TCu380A (copper) IUD expulsion after immediate insertion at vaginal delivery has been 
limited to self-reported outcomes,7 small sample sizes,8,9 and international data that may not 
be generalizable to the U.S.10–12 Reports of 3- to 6-month expulsion rates range from 7.0–
19.5% after vaginal delivery.9–12
This prospective, observational study of IUD position outcomes after postplacental 
placement of copper IUDs after vaginal delivery was designed to determine the proportion 
of IUDs expelled, partially expelled, malpositioned, and continued by 6 months postpartum, 
to evaluate contraceptive method use at 6 months, and to determine risk factors for IUD 
expulsion and partial expulsion.
Materials and Methods
All study activities were approved by the Hospital of the University of Pennsylvania 
Institutional Review Board. We recruited women between April 2015 and August 2016. We 
included English-speaking women who were 18 years of age or older, delivered vaginally at 
34 weeks 0 days’ gestation or more, received a postplacental TCu380A IUD, and who were 
willing to participate in study follow-up after hospital discharge. We excluded women who 
were unwilling or unable to comply with the study protocol.
Provision of postplacental IUDs was initiated as a part of clinical care at our university 
hospital starting in January 2014. We made efforts to increase awareness by providers and 
patients of the option for postplacental IUD placement from January 2014 onward, unrelated 
to the research study setting. Levonorgestrel IUDs were not available on our obstetrics ward. 
Obstetric providers were trained in postplacental IUD placement with both ring forceps and 
manual insertion, and booster trainings were provided to the Labor and Delivery service 
monthly. Transabdominal ultrasound to guide or confirm IUD placement was used at the 
discretion of the provider. IUDs were provided through philanthropic funding13 or, after 
April 2015, through a combination of philanthropic and research funding. Medical 
assistance did not cover immediate postpartum LARC during the study period.
Potentially eligible participants were approached prior to postpartum discharge by a study 
coordinator. Eligible women provided written informed consent in the postpartum unit, or 
were given the option to enroll by telephone after discharge. Women wishing to enroll after 
discharge were contacted within 6 weeks by a study coordinator and provided verbal 
consent. A baseline questionnaire including demographic information, obstetric and 
contraceptive history, and satisfaction with the postplacental IUD was administered at the 
time of enrollment. Labor characteristics, delivery information, and neonatal information 
were abstracted from the medical record after delivery using a standardized form.
The primary outcome for this study was the proportion of IUDs expelled at 6 months. 
Secondary outcomes were IUD position (partial expulsion, malposition, or correct position), 
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elective removal, and contraceptive method use at 6 months postpartum. We defined a partial 
expulsion as an IUD protruding from the external cervical os, or a transvaginal ultrasound 
showing the distal end of the IUD below the internal os of the cervix. Malposition was 
defined as an IUD that was lower than 1cm from the fundus, or in an abnormal orientation, 
but not partially expelled.
IUD location and participant satisfaction with the IUD were assessed at 6 weeks and 6 
months postpartum. At 6 weeks postpartum, the research staff extracted data from the 
medical record to obtain information about IUD position. Participants with incomplete 
documentation of IUD status in the medical record (that is, no documentation of strings on 
exam, documentation of absent or long strings but no ultrasound ordered, or ultrasound 
ordered but not performed), and those who did not follow up with their provider, were 
recalled for a visit in the research office at 6 weeks. Research visits included a pelvic 
examination and transvaginal ultrasound to evaluate IUD position. Participants who were 
diagnosed with an IUD problem during this visit were offered a same-day clinical 
appointment for contraceptive counseling, and if necessary, IUD removal and initiation of a 
new method, including all LARC methods. Additionally, a questionnaire was administered 
either in person or over the phone to assess satisfaction (using a 5-item Likert scale, “How 
happy are you with your choice to get the IUD immediately,” with the bounds “extremely 
unhappy” to “extremely happy”), participant-reported IUD status (reported as “in place” or 
“expelled”), and performance of self-string check (reported as “yes” or “no”).
Participants returned at 6 months for an in-person study visit with a research clinician. 
Procedures at this visit included a pelvic exam with string check and a transvaginal 
ultrasound. Participants diagnosed with an IUD problem at 6 months were also offered a 
clinical appointment for same-day contraceptive management. We administered the same 
study questionnaire to assess satisfaction, participant-reported IUD status, and performance 
of self-string check. Participants were compensated for time and participation.
Our sample size was computed assuming that 15% of IUDs would be expelled by 6 months 
postpartum.11,14,15 A sample size of 150 participants provided a narrow 95% confidence 
interval of +/− 5.3% around this expected expulsion percentage. We planned to enroll 200 
participants, anticipating 25% loss to follow up by 6 months.
We analyzed baseline demographic and reproductive health variables for all participants 
using standard descriptive statistics. We distinguished between full and partial expulsion and 
computed the proportion of IUDs in each category. For the primary outcome of IUD 
expulsion at 6 months postpartum, we used one-way Analysis of Variance or Kruskal-Wallis 
tests for continuous variables and Fisher’s exact test for categorical variables, to initially 
assess associations. We performed a multinomial (polytomous) logistic regression analysis, 
including demographic variables (age, BMI category, race/ethnicity, income category, and 
relationship status) as well as variables where p≤0.20 from bivariate tests (parity, gestational 
age at delivery, IUD placement method, provider specialty, maternal weight gain, time to 
IUD placement) were considered. From this set, we used a backward elimination strategy to 
confirm all factors that were significantly associated with complete IUD expulsion or partial 
IUD expulsion or confounded associations of interest. The area under the receiver-operating 
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characteristics (ROC) curve was used to assess the ability of a string check to predict the 
correct placement of a postplacental IUD.
Study data were collected and managed using electronic standardized data abstraction forms 
in REDCap (Research Electronic Data Capture, Vanderbilt University). We used Stata 14.2 
(StataCorp, College Station, TX) for all statistical analyses. This prospective cohort study 
was conducted in accordance with the protocol registered on ClinicalTrials.gov, 
NCT02706340.
Results
We approached 234 women, and enrolled 200. The most common reason for declining 
participation was unwillingness to participate in research (n=31). Three potential subjects 
were ineligible, 5 women were found to be ineligible after enrollment (screen fail), and 4 
participants withdrew prior to 6 months (Figure 1). Baseline characteristics including 
demographic characteristics for the entire cohort are shown in Table 1. The median time 
between delivery of the placenta and placement of the IUD was 4 minutes (range 0–26 min). 
A total of 11 IUDs (5.5%) were inserted greater than 10 minutes after placental delivery. 
Ultrasound guidance assisted in the placement of 4 IUDs for study participants.
Thirty-three subjects did not have the status of their IUD confirmed at 6 months, either due 
to loss to follow-up or withdrawn consent. A sensitivity analysis evaluating these 
participants’ baseline characteristics found no difference in comparison to participants who 
did complete the study, in all categories except BMI. Participants without outcome data were 
more likely to have an unknown BMI (36.4% vs 13.0%) and more likely to be overweight 
(30.3% vs 21.6%, p<0.01).
Among the 162 participants with available data on IUD status at 6 months, 13 (8.0%, 95% 
CI 4.7%–13.4%) had a complete IUD expulsion, and 26 (16.0%; 11.1%–22.6%) had a 
partial IUD expulsion. Of 25 malpositioned IUDs (15.4%, 95% CI 10.2%–21.9%), 14 were 
not at the fundus (8.6%, 95% CI 5.2%–14.1%) and 11 were rotated within the uterus (6.8%, 
95% CI 3.8%–11.9%). Five IUDs (3.1%, 95% CI 1.3%–7.3%) were removed electively, and 
2 (1.2%, 95% CI 0.3%–4.9%) were removed because of infection. Ultrasound examination 
was not consistently performed to establish IUD position prior to elective removal, as these 
removals were performed in the clinical, not research, setting. One participant (0.6%, 95% 
CI 0%–4.3%), whose provider visualized and trimmed IUD strings at a 6-week postpartum 
visit, was diagnosed by ultrasound at 6 months with an IUD perforation. Her IUD was noted 
to be upside-down, with the stem partially perforated through the anterior lower uterine 
segment of the uterus and the arms in the endocervix (Figure 2). This device was 
subsequently removed via hysteroscopy and she opted against a new contraceptive method.
Ninety participants (55.6%, 95% CI 44.7%–63.1%) had their original IUD in the correct 
position and continued to use it for contraception after the 6-month study visit. Of women 
with a compete expulsion, 9 of 13 (69.2%; 95% CI 38.6%–90.9%) were recognized by the 
participant prior to clinical examination. Most women diagnosed with an abnormally 
positioned IUD had both the desire and the access to have a new LARC placed at the time of 
GURNEY et al. Page 5
Am J Obstet Gynecol. Author manuscript; available in PMC 2019 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
this diagnosis. Thus, despite the overall low proportion of women at 6 months continuing 
with their original IUD, a total of 132 (80.9%) women in our cohort were using a highly 
effective method at 6 months (Table 2). Two subjects (1.2%, 95% CI 0%–4.4%) experienced 
a new pregnancy within 6 months of delivery.
Thirty-four of 142 participants (23.9%, 95% CI 17.2%–31.8%) who were seen in the office 
at 6 weeks, and had not had an IUD removal, had no strings visible. Sixty-three percent 
(95% CI 55.0%–76.0%) of women who were later confirmed to have an abnormally 
positioned IUD had strings visible, and 84.5% (95% CI 75.0%–91.5%) of women who were 
later confirmed to have a correctly positioned IUD had strings visible. Thus, the sensitivity 
and specificity of an IUD string check for predicting correct 6-month positioning of the 
device was 36.2% and 84.5%, respectively (Figure 3). This corresponds to an area under the 
receiver operating characteristics curve of 0.5. Among the 51 participants who had a partial 
IUD expulsion or malposition, additional follow up to assess or correct the IUD was 
required.
Unadjusted associations between risk factors and our outcome (IUD expulsion, IUD partial 
expulsion, and all other IUD outcomes) are presented in Table 1. Parity, gestational age, IUD 
placement method (ring forceps compared with manual insertion), provider specialty 
(Obstetrics and Gynecology compared with Family Medicine), time to IUD placement 
(greater than 10 minutes from placental delivery as compared with 10 minutes or fewer), and 
gestational weight gain categories as defined by the Institute of Medicine16 were all 
associated with IUD expulsion and partial expulsion with a p-value of 0.2 or less. Thus, we 
included these variables in a multinomial logistic regression model where only significant 
risk factors and identified confounding variables were retained, to assess factors associated 
with complete and partial expulsion. In this adjusted analysis, each additional prior delivery 
(higher parity) increased the odds of complete expulsion twofold (OR 2.05; 95% CI 21–
3.49, p=0.008). Covariates associated with partial expulsion included insertion by an 
Obstetrics and Gynecology provider (as compared to a Family Medicine provider; OR 5.31, 
95% CI 1.20–23.60; p=0.03) and gestational weight gain category (normal compared to 
excess; OR 9.12, 95% CI 1.90–43.82; p=0.006). These associations were adjusted for 
gestational age and time to IUD placement, which were noted to be confounders.
Of the 143 women who completed a satisfaction survey at 6 months, 110 (76.9%, 95% CI 
69.1%–83.6%) were happy or extremely happy with the IUD. The majority of survey 
respondents (36 of 62, 61.3%, 95% CI 44.8%–70.5%) who experienced an IUD problem 
(including expulsion, partial expulsion, malposition, and removal for other reasons) and 
completed the study were happy or extremely happy with the IUD, and 12 (19.4%, 95% CI 
10.4%–31.4%) were neither happy nor unhappy with the IUD.
Comment
In this prospective cohort study of women who received a copper IUD immediately after 
vaginal delivery, 8.0% had a complete IUD expulsion, and 24.0% had complete or partial 
expulsion by 6 months. The 6-month complete expulsion rate was 8.0% (95% CI 4.7%–
13.4%), 69.2% of which were recognized by the participants prior to clinical examination. 
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When also considering women who had partially expelled or malpositioned IUDs, and those 
who had their IUDs removed, only 55.6% of participants had the original IUD in place at 6 
months. We allowed same-day clinical appointments for contraceptive management, 
including LARC, for subjects diagnosed with an IUD problem during a study visit; so 
despite relatively low continuation of the original IUD, 80.9% of women with follow-up 
were using an IUD or an implant at 6 months postpartum.
Prior studies have shown that IUD expulsion occurs more frequently when placed 
immediately after placental delivery as compared with standard placement, but many of 
these studies have been limited by small sample sizes that prevented accurate determination 
of expulsion rates.17 In studies of IUD expulsion, the method of detection is central to the 
interpretation of the partial and complete expulsion rate. Previous similar studies of IUD 
expulsion after placement immediately postpartum have assessed expulsion via a variety of 
methods: provider pelvic exam and string check,18 participant self-report,7,18,19 ultrasound 
to confirm expulsion,10,11 or ultrasound for all participants.9,20,21 Study protocols also have 
used a combination of these strategies.10,18,19 The expulsion rate in our study is concordant 
with other studies that used ultrasound universally for assessment of IUD position, although 
the complete expulsion rate in our study is lower than that noted for the LNG IUD.9,20,22
Without using ultrasound as a detection modality, partial expulsion is not well predicted 
clinically; even ultrasound 24 hours postpartum does not predict complete expulsion.9 
Although the degree to which a partially expelled copper IUD compromises contraceptive 
efficacy is not fully understood, prior studies comparing the copper T380A to the T380S 
have shown that moving the copper closer to the cornua is associated with higher efficacy, 
and that IUDs with no copper near the cornua have lower efficacy.23–25 Thus, partially 
expelled and even malpositioned copper IUDs may result in compromised efficacy. In a 
case-control study of women found to be pregnant with a copper IUD in situ, the odds of 
pregnancy for a woman with an IUD in the endocervix versus an IUD in the endometrial 
canal was 13.93 (95% CI 4.13–48.96).26
Our study found that the sensitivity and specificity of the IUD string check as a test for 
correct IUD positioning are overall low; only 36.2% of women who eventually were 
diagnosed with an abnormally positioned IUD had no strings visible, and 84.5% of women 
with a correctly positioned IUD had strings visible. Although string visibility confirms the 
presence of the IUD, identifying strings on pelvic examination does not ensure correct 
intrauterine placement, and cannot be considered clinically reassuring. Similarly, the 
absence of strings on examination does not diagnose an expulsion. Our finding that the area 
under the receiver operating characteristics curve was 0.5 demonstrates that a string check is 
a poor test for assessing whether a postplacental IUD is correctly positioned. Even for 
women who have an interval IUD insertion, many women are unable and/or unwilling to 
perform monthly IUD string palpation,27 and in a population of women who have had a 
postplacental IUD, recommending self-palpation of strings would be especially unhelpful.
Our findings suggest that women who have had a postplacental IUD should have a health 
care provider assess their IUD position at a postpartum visit, preferably with sonographic 
imaging. However, there are many potential limitations to this recommendation. Ultrasound 
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is unlikely to be readily available in low-resource settings, and many women do not return 
for postpartum visits28–30. Underinsured women enrolled in Emergency Medicaid for their 
pregnancy may face restrictions on additional procedures after delivery, such as pelvic 
ultrasound or removal and replacement of an abnormally positioned IUD, especially because 
Emergency Medicaid covers only a finite number of weeks postpartum. In our study 
population, 10 women continued an IUD with a positional problem due to insurance barriers 
to replacement, illustrating this disappointing void in healthcare access. Patients insured by 
Emergency Medicaid should be counseled in the antenatal period regarding these logistics, 
and on issues such as the cost of IUD removal services, if needed outside of the insured 
period. The American College of Obstetricians and Gynecologists and others have 
recommended revising the timing of the initial postpartum visit to two or three weeks 
postpartum,1,31 which could provide sufficient time for confirmation of IUD position, and 
correction if needed, prior to loss of insurance.
Our multivariable analysis of risk factors contributing to postplacental IUD expulsion by 6 
months postpartum found that higher parity and ring forceps insertion of the IUD were 
associated with complete IUD expulsion. Each prior delivery was associated with a twofold 
increase in odds of complete IUD expulsion, which is consistent with prior research.21 The 
clinical significance of the covariates associated with partial IUD expulsion in our study, 
provider specialty and gestational weight gain, is unclear.
Strengths of this study include its prospective nature, the diverse participant population, and 
longitudinal follow-up with a high retention rate. Importantly, in contrast to many prior 
studies of postplacental IUDs, detection of the IUD location outcome was obtained in person 
and with ultrasound, which allowed for a detailed description and understanding of the 
varied positions that may result after an IUD is placed immediately following placental 
delivery. Our study also had limitations. We constrained the study to the copper IUD, as 
levonorgestrel IUDs were not available for postplacental placement during this time period 
at our institution. Thus, our outcomes are not generalizable to women receiving 
postplacental levonorgestrel IUDs, for which partial expulsion or malposition might not 
result in significant decreases in efficacy32. Satisfaction in our study was measured via a 5-
item Likert scale; there are likely to be additional nuances in patient satisfaction that were 
not captured via our survey. Finally, our study is subject to the biases of observational 
studies, and any associations cannot imply causality.
Unlike interval IUDs, retained postplacental IUDs have high frequencies of abnormal 
positioning at 6 months, including complete expulsion, partial expulsion, and malposition. 
Patients who choose an IUD are counseled that that they are receiving the highest tier of 
contraceptive effectiveness in a low-maintenance method. Women considering a 
postplacental IUD, especially those with limited time periods of insurance coverage and in 
low-resource settings, should be made aware of the risk of IUD position abnormalities after 
postplacental placement, as well as the possibility of non-visible IUD strings complicating 
follow-up and IUD removal. Thus, we recommend that a detailed consent process for 
postplacental IUD placement, including the risks, benefits, alternatives (including interval 
IUD placement) and logistics occur in an outpatient antenatal setting, in order to allow 
sufficient time for informed decision-making. Furthermore, the clinical significance of IUD 
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position abnormalities and partial expulsion is currently unknown, and future research 
should evaluate the effectiveness of postplacental IUDs and resultant variations in IUD 
position in a large, multicenter prospective trial.
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Condensation:
Of women who choose and receive a postplacental copper IUD after vaginal delivery, 
8.0% (95% CI 4.7%–13.4%) experience complete expulsion and 16.0% (95% CI 11.1%–
22.6%) have partial expulsion of the device at 6 months postpartum.
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Implications and Contributions:
A. To describe positional outcomes of postplacental copper IUDs placed after 
vaginal delivery.
B. Eight percent of immediate postplacental IUDs were completely expelled, and 
16% partially expelled, by 6 months postpartum. Only 55.6% of participants 
continued using their original IUD at 6 months, but 80.9% were using a 
LARC method. The sensitivity of a string check to detect an incorrectly 
positioned IUD was 36.2%, and the specificity of a string check to predict a 
correctly positioned IUD was 84.5%. Three-quarters of immediate 
postplacental IUD users were happy or extremely happy with the IUD.
C. This study provides a detailed description of postplacental IUD position at 6 
months postpartum, and finds that a string check is a poor test to confirm 
correct IUD position.
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Figure 1: 
Study flow: recruitment, enrollment, and intrauterine device status.
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Figure 2: 
Midsaggital transvaginal ultrasound demonstrating intrauterine device perforated through 
anterior uterine wall (arrow).
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Figure 3: 
Visibility of intrauterine device strings at 6 week exam and final intrauterine device position 
outcome at 6 months.
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Table 1.
Baseline characteristics and IUD expulsion or partial expulsion at 6 months postpartum.
Characteristic Total (n=162)
Complete Expulsion (n=13) Partial Expulsion (n=26) Other IUD 
Outcomea 
(n=123)
 P-value
Age (years) 27.7 ± 5.1 29.9 ± 4.8 27.7 ± 4.8 27.5 ± 5.1 0.26
Parity 2 (2, 2) 4 (2, 4) 2 (2, 3) 2 (2, 3) 0.02
Gestational age at delivery 39 1/7 (38 0/7, 40 
1/7)
38 1/7 (37 0/7, 40 1/7) 39 2/7 (39 0/7, 40 3/7) 39 1/7 (38 0/7, 
40 0/7)
0.04
BMI (kg/m2)
 Unknown 21 (13.0) 2 (15.4) 3 (11.5) 16 (13.0) 0.68
 Normal (<24.9) 50 (30.9) 3 6 (23.1) 41 (33.)
 Overweight (25–29.9) 35 (21.6) 5 (38.5) 6 (23.1) 24 (19.5)
 Obese (>30) 56 (34.6) 3 (23.1) 11 (42.3) 42 (34.2)
Race / Ethnicity American
 Black / African 122 (75.3) 9 (69.2) 20 (76.9) 93 (75.6) 0.67
 White 20 (12.4) 2 (15.4) 2 (7.7) 16 (13.0)
 Asian/Indian 6 (3.7) 1 (7.7) 0 5 (4.1)
 Hispanic 11 (6.8) 1 (7.7) 3 (11.5) 7 (5.7)
 Other 3 (1.9) 0 1 (3.9) 2 (1.6)
Annual income
 <$10,000 46 (28.4) 3 (23.1) 4 (15.4) 39 (31.7) 0.50
 10,001–30,000 39 (24.1) 4 (30.8) 7 (26.9) 28 (22.8)
 >30,001 77 (47.5) 6 (46.2) 15 (57.7) 56 (45.5)
Relationship status
 Single 51 (31.5) 5 (38.5) 8 (30.8) 38 (30.9) 0.82
 With a partner 69 (42.6) 4 (30.8) 10 (38.5) 55 (44.7)
 Married or divorced 42 (25.9) 4 (30.8) 8 (30.8) 30 (24.4)
IUD placement method
 Manual 131 (80.9) 7 (53.9) 18 (69.2) 106 (86.2) <0.01
 Ring forceps 16 (9.3) 4 (30.8) 2 (7.7) 9 (7.3)
 Unknown 16 (9.9) 2 (15.4) 6 (23.1) 8 (6.5)
Provider specialty
 OB 143 (88.3) 13 (100) 19(73.1) 111 (90.2) 0.03
 Family Medicine 19 (11.7) 0 7 (26.9) 12 (9.8)
Maternal weight gainb
 Normal 102 (68.5) 8 (66.7) 20 (87.0) 74 (64.9) 0.10
 Above recommendation 47 (31.5) 4 (33.3) 3 (13.0) 40 (35.1)
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Characteristic Total (n=162)
Complete Expulsion (n=13) Partial Expulsion (n=26) Other IUD 
Outcomea 
(n=123)
 P-value
Time to IUD placement
 ≤ 10 minutes 136 (84.0) 11 (84.6) 22 (84.6) 103 (83.7) 0.23
 > 10 minutes 9 (5.5) 2 (15.4) 0 7 (5.7)
 Unknown 17 (10.5) 0 4 (15.4) 13 (10.6)
Data are mean ± standard deviation, median (IQR), or n (%).
aOther outcomes at 6 months were: correctly positioned IUD, malpositioned IUD, perforation, and IUD removed without ultrasound assessment.
bAccording to Institute of Medicine recommendations14 based on maternal BMI.
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Table 2.
Contraceptive outcomes at 6 months postpartum among 162 women receiving a postplacental IUD after 
vaginal delivery.
Contraceptive outcome n % (95% CI)
TCu380A IUD 121 74.7 (67.5–80.8)
   Original IUD, correctly positioned 90 55.6 (44.7–63.1)
   Replacement TCu380A IUD 21 13.0 (8.6–19.0)
   Abnormal position, continuing abnormally placed
IUDa
      Partial expulsion 3 1.9 (0.6–5.3)
      Malpositioned
         Not at fundus 4 2.5 (1.0–6.2)
         Rotated 3 1.9 (0.6–5.34)
Levonorgestrel IUD 9 5.6 (3.0–10.2)
Etonogestrel implant 1 0.6 (0.1–3.4)
Hormonal method 7 4.3 (2.1–8.7)
Condoms 9 5.6 (3.0–10.2)
Emergency contraception 1 0.6 (0.1–3.4)
None, abstinence, withdrawal 13 8.0 (4.8–13.2)
Tubal sterilization 1 0.6 (0.1–3.4)
aUnable to replace IUD due to logistical barriers.
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Table 3.
Risk factorsa associated with complete and partial IUD expulsion among women receiving immediate 
postplacental copper IUDs.
Odds Ratio 95% CI p-value
Complete Expulsion compared to other IUD outcomeb
 Parity 2.05 1.21–3.49 <0.01
Partial Expulsion compared to other IUD outcomeb
 Provider Specialty
  Family Medicine 1
  Obstetrics & Gynecology 5.31 1.20–23.60 0.03
 Maternal Weight Gainc
  Excess 1
  Normal 9.12 1.90–43.82 <0.01
aCovariates in multinomial logistic regression model were: IUD status at 6 months postpartum, parity, gestational age at delivery, provider 
specialty, IUD placement method, time to IUD placement, and maternal weight gain.
bOther outcomes at 6 months were: correctly positioned IUD, malpositioned IUD, perforation, and IUD removed without ultrasound assessment.
cAs defined by the Institute of Medicine.
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